In this week’s episode, Iain MacLeod Ph.D., co-founder, CEO and Chief Science Officer of Aldatu Biosciences, joins Mark in discussing a range of issues related to virology and public health – and why we can’t “vaccinate our way out of the pandemic”. Topics include: How Iain became interested in pathology and virology What motivated Iain…
Read More
Richard Nugent is passionate about helping others make the most of their innovations. His expertise is Intellectual Property Strategy, Competitive Intelligence, IP Training, and related services. On this episode of When Science Speaks, we discuss a range of issues related to translating science into the commercial realm, including; – Richard’s methodology for working with PhDs and…
Read More
Nathaniel Brooks Horwitz has had a set of rare experiences – particularly for someone still in the early stages of his career journey. His passion is to develop new medicines. A Principal at RA Capital, a leading biotech venture capital firm in Boston, MA, Board Member at Synthego Corporation, Quench Bio, GentiBio and others, Nathaniel…
Read More
In this episode, Ihklaq Sidhu, PhD and Mike Grandinetti share information about “Global Venture Catalyst”, a new hands-on, entrepreneurial education initiative they’re launching to provide 500 engineers, technical students, and business school students around the world a transformative experience to work in diverse teams to develop new hight-impact projects. Today’s topics include: Details about the…
Read More
On this episode, Mark discusses a range of translational research issues with Mike Fenn, PhD, the Director of Healthcare & Life Sciences at Harvard Innovation Labs, including: What led Mike to focus on life sciences virtually from the start of his professional career From Mike’s perspective, what all successful startups have in common, and what…
Read More
In this week’s episode, Mark and Marc discuss innovation in the life sciences industry, including the recent launch of Orange Grove’s portfolio company, Asalyxa Bio. Topics include: Remdesivir and Marc’s view on this experimental medicine for combatting effects of COVID-19 Why Marc decided to focus his professional life on funding innovations in health care and…
Read More
Fabricio F. Costa, PhD is a science and technology expert, seasoned business strategist, and serial entrepreneur with more than 20 years of experience in top academic labs and companies including Harvard University, Northwestern University, Google, Apple, and others. On this episode of When Science Speaks, Mark and Fabricio discuss a range of topics, including: How Fabrizio…
Read More
Vinit Nijhawan is Managing Director of MassVentures, the first public venture capital fund in the U.S., funding early stage, high growth Massachusetts companies for more than 40 years. In this episode, Mark and Vinit discuss a range of topics related to innovation and entrepreneurship, including: The skills that have been central contributors to Vinit’s success…
Read More
In this week’s episode, John Younger, MD, Vice President for Science and Technology at University City Science Center in Philadelphia, PA, shares his expert perspectives as a physician-scientist and biotech entrepreneur. Drawing upon his unique blend of skills and experience, John discusses: The main ingredients of a winning pitch from startups to potential investors Typical…
Read More
Mark Bayer: [00:00:39] Hey, everyone. This is Mark Bayer. And thanks so much for tuning in to this week’s episode of When Science Speaks. Today’s episode is brought to you by Bayer Strategic Consulting in Washington, D.C., which helps scientists and engineers get funding, gain influence and build relationships with the stakeholders who matter most….
Read More